| Literature DB >> 35439963 |
Sha Huang1, Lingdan Zhao2, Zhaoyuan Liu1, Yang Li1, Xi Wang3, Jianqun Li2, Xiaoyan Chen4.
Abstract
BACKGROUND: Community-acquired pneumonia (CAP) causes high morbidity and mortality in all age groups worldwide. Lower muscle radiodensity was associated with worse clinical outcomes (including shock) and higher in-hospital mortality. Prompt detection of sarcopenia in older adults with CAP is important. The measurement of muscle mass often involves specialized and expensive techniques. A relatively simple and inexpensive method such as the sarcopenia index (SI) to measure muscle mass would be helpful. Therefore, we performed a retrospective cohort study to assess the association between SI and septic shock risk and mortality in older patients with CAP. STUDYEntities:
Keywords: Mortality; Older adults; Pneumonia; Sarcopenia index; Septic shock; Serum creatinine; Serum cysteine C
Mesh:
Substances:
Year: 2022 PMID: 35439963 PMCID: PMC9020066 DOI: 10.1186/s12877-022-03029-z
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Baseline characteristics of participants according to the SI
| Characteristics | Total | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 82.08(8.94) | 76.93(9.38) | < 0.001 | 79.24(9.91) | 76.4(9.5) | 0.005 | 82.66(8.24) | 77.31(9) | < 0.001 | |
| 32.81(6.1) | 37.6(5.72) | < 0.001 | 32.78(5.84) | 37.31(5.62) | < 0.001 | 34.88(6.73) | 38.76(5.48) | < 0.001 | |
| 119(62.96) | 162(28.32) | 75(63.56) | 103(28.85) | 67(56.78) | 36(21.43) | ||||
| 70(37.04) | 410(71.68) | 43(36.44) | 254(71.15) | 51(43.22) | 132(78.57) | ||||
| 21.52(2.43) | 21.82(3.05) | 0.204 | 21.64(2.82) | 21.66(3.01) | 0.934 | 21.5(2.5) | 22.33(3.08) | 0.011 | |
| 125.61(63.42) | 85.16(31.17) | < 0.001 | 135.75(67.06) | 84.95(29.3) | < 0.001 | 107(46.53) | 74.92(25.66) | < 0.001 | |
| < 0.001 | 0.002 | 0.85 | |||||||
| no | 158(82.29) | 314(54.42) | 62(52.1) | 130(36.01) | 70(97.22) | 210(96.77) | |||
| yes | 34(17.71) | 263(45.58) | 57(47.9) | 231(63.99) | 2(2.78) | 7(3.23) | |||
| < 0.001 | 0.594 | 0.046 | |||||||
| no | 165(85.94) | 409(71.01) | 75(63.03) | 217(60.28) | 68(94.44) | 214(98.62) | |||
| yes | 27(14.06) | 167(28.99) | 44(36.97) | 143(39.72) | 4(5.56) | 3(1.38) | |||
| 0.569 | 0.762 | 0.697 | |||||||
| no | 112(58.33) | 350(60.66) | 69(57.98) | 215(59.56) | 57(79.17) | 167(76.96) | |||
| yes | 80(41.67) | 227(39.34) | 50(42.02) | 146(40.44) | 15(20.83) | 50(23.04) | |||
| 0.02 | 0.073 | 0.04 | |||||||
| no | 144(75) | 477(82.67) | 92(77.31) | 305(84.49) | 37(51.39) | 141(64.98) | |||
| yes | 48(25) | 100(17.33) | 27(22.69) | 56(15.51) | 35(48.61) | 76(35.02) | |||
| 0.238 | 0.256 | 0.024 | |||||||
| no | 125(65.1) | 402(69.67) | 82(68.91) | 268(74.24) | 36(50) | 141(64.98) | |||
| yes | 67(34.9) | 175(30.33) | 37(31.09) | 93(25.76) | 36(50) | 76(35.02) | |||
| 0.001 | 0.081 | 0.734 | |||||||
| no | 164(85.42) | 426(73.83) | 89(74.79) | 239(66.2) | 66(91.67) | 196(90.32) | |||
| yes | 28(14.58) | 151(26.17) | 30(25.21) | 122(33.8) | 6(8.33) | 21(9.68) | |||
SI sarcopenia index, ALB serum albumin, CHD coronary heart disease, COPD chronic obstructive pulmonary disease
Differences in the distribution of septic shock and mortality between patients with low SI and high SI
| Characteristics | Total | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.153 | 0.19 | 0.024 | |||||||
| no | 155(80.73) | 491(85.1) | 94(78.99) | 304(84.21) | 56(77.78) | 192(88.48) | |||
| yes | 37(19.27) | 86(14.9) | 25(21.01) | 57(15.79) | 16(22.22) | 25(11.52) | |||
| < 0.001 | < 0.001 | < 0.001 | |||||||
| no | 71(36.98) | 366(63.43) | 44(36.97) | 219(60.66) | 19(26.39) | 155(71.43) | |||
| yes | 121(63.02) | 211(36.57) | 75(63.03) | 142(39.34) | 53(73.61) | 62(28.57) | |||
Correlations between SI and spetic shock
| Adverse reactions | Total | Male | Female | |||
|---|---|---|---|---|---|---|
| Spetic shock | ||||||
| low SI (ref) | 1 | 1 | 1 | 1 | 1 | 1 |
| high SI | 0.73(0.48–1.12) | 0.91(0.53–1.59) | 0.71(0.42–1.19) | 1.12(0.57–2.19) | 0.46(0.23–0.91)* | 0.38(0.16–0.94)* |
Model 1: a non-adjusted model
Model 2: adjusting for age, gender, smoking history, drinking history, BMI, eGFR, ALB level, and disease (hypertension, diabetes, CHD, COPD)
*P < 0.05
Correlations between SI and mortality
| Adverse reactions | Total | Male | Female | |||
|---|---|---|---|---|---|---|
| low SI(ref) | 1 | 1 | 1 | 1 | 1 | 1 |
| high SI | 0.44(0.35–0.55)* | 0.64(0.48–0.84)* | 0.46(0.34–0.6)* | 0.69(0.49–0.97)* | 0.26(0.18–0.37)* | 0.39(0.24–0.62)* |
Model 1: a non-adjusted model
Model 2: adjusting for age, gender, smoking history, drinking history, BMI, eGFR, ALB level, and disease (Hypertension, diabetes, CHD, COPD)
*P < 0.05